speb/financial-data huggingface dataset:
AMGN.TO cash_flow (annual, 2024-12-31) — Operating Gains Losses: 159000000.00
AMGN.TO income_statement (annual, 2024-12-31) — Operating Income: 7258000000.00
AMGN.TO income_statement (annual, 2024-12-31) — Operating Revenue: 32026000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 537000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Other Current Assets: 1138000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 308000000.00
AMGN.TO income_statement (annual, 2024-12-31) — Other Income Expense: 506000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 27699000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Other Non Cash Items: -177000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 9930000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 2349000000.00
AMGN.TO income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 506000000.00
AMGN.TO income_statement (annual, 2024-12-31) — Other Operating Expenses: 248000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Other Properties: 4996000000.00
AMGN.TO balance_sheet (quarterly, 2024-12-31) — Other Properties: 4996000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Payables: 5769000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 18220000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1329000000.00
AMGN.TO balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1329000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Prepaid Assets: 2139000000.00
AMGN.TO balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 2139000000.00
AMGN.TO income_statement (annual, 2024-12-31) — Pretax Income: 4609000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Properties: 0.00
AMGN.TO balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
AMGN.TO cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
AMGN.TO cash_flow (annual, 2024-12-31) — Purchase Of Investment: 0.00
AMGN.TO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -1096000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Raw Materials: 818000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Receivables: 6782000000.00
AMGN.TO income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 12858000000.00
AMGN.TO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 5592000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Repayment Of Debt: -3600000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -200000000.00
AMGN.TO income_statement (annual, 2024-12-31) — Research And Development: 5964000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Retained Earnings: -27590000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Sale Of Investment: 0.00
AMGN.TO cash_flow (quarterly, 2024-12-31) — Sale Of Investment: 0.00
AMGN.TO income_statement (annual, 2024-12-31) — Selling General And Administration: 7096000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Share Issued: 537000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Stock Based Compensation: 530000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 5877000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Tangible Book Value: -40459000000.00
AMGN.TO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
AMGN.TO income_statement (annual, 2024-12-31) — Tax Provision: 519000000.00
AMGN.TO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.11
AMGN.TO balance_sheet (annual, 2024-12-31) — Taxes Receivable: 198000000.00
AMGN.TO balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 198000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Total Assets: 91839000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Total Capitalization: 62426000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Total Debt: 60099000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 5877000000.00
AMGN.TO income_statement (annual, 2024-12-31) — Total Expenses: 26166000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 85962000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 62809000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 62863000000.00
AMGN.TO income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 7258000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Total Tax Payable: 2583000000.00
AMGN.TO balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 2583000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Tradeand Other Payables Non Current: 2349000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Work In Process: 4120000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Working Capital: 5931000000.00
AMGN.TO income_statement (quarterly, 2025-03-31) — +Operating Expense: 4003000000.00
AMGN.TO income_statement (quarterly, 2025-03-31) — +Total Revenue: 8149000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 2406000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 8132000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -10600000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 800000000.00
AMGN.TO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 9774618731.00
AMGN.TO income_statement (quarterly, 2025-03-31) — Basic EPS: 0.18
AMGN.TO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 11973000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -411000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 33578000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 8810000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 8810000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -1279000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -4107000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -447000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 1391000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 497000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Change In Income Tax Payable: 174000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Change In Inventory: 288000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -201000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -78000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -388000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Change In Payable: 671000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 671000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Change In Receivables: -1308000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Change In Tax Payable: 174000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -1016000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -1308000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -3163000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 33578000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -1279000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 6207000000.00
AMGN.TO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 2968000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 17234000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Current Assets: 26929000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Current Debt: 3368000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 3368000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 23008000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -250000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Deferred Tax: -250000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Depreciation: 1387000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 1387000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 1387000000.00
AMGN.TO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 9829124040.00
AMGN.TO income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.18
AMGN.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 1730000000.00
AMGN.TO income_statement (quarterly, 2025-03-31) — EBIT: 2696000000.00
AMGN.TO income_statement (quarterly, 2025-03-31) — EBITDA: 4083000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 8810000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -4107000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Finished Goods: 1927000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 980000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -1295000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -231000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Goodwill: 18645000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 44369000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 17281000000.00
AMGN.TO income_statement (quarterly, 2025-03-31) — Gross Profit: 5181000000.00
AMGN.TO income_statement (quarterly, 2025-03-31) — Interest Expense: 723000000.00
AMGN.TO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 723000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Inventory: 6729000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 63588000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -447000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 54013000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 54013000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -2500000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Net Debt: 48571000000.00
AMGN.TO income_statement (quarterly, 2025-03-31) — Net Income: 1730000000.00
AMGN.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 1730000000.00
AMGN.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 1730000000.00
AMGN.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 1730000000.00
AMGN.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 1730000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 1730000000.00
AMGN.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 1730000000.00
AMGN.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: -723000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -2500000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -2500000000.00
AMGN.TO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -723000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -328000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -36000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 6681000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -411000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -38162000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 1510000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 1510000000.00
AMGN.TO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 4083000000.00
AMGN.TO income_statement (quarterly, 2025-03-31) — Normalized Income: 1730000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 1391000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -1295000000.00
AMGN.TO income_statement (quarterly, 2025-03-31) — Operating Income: 1178000000.00
AMGN.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 7873000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 537650624.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 3258000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -231000000.00
AMGN.TO income_statement (quarterly, 2025-03-31) — Other Income Expense: 1518000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 25724000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -50000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 11388000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 2210000000.00
AMGN.TO income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 1518000000.00
AMGN.TO income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 830000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Payables: 2406000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 19640000000.00
AMGN.TO income_statement (quarterly, 2025-03-31) — Pretax Income: 1973000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -411000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Raw Materials: 841000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Receivables: 8132000000.00
AMGN.TO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 2968000000.00
AMGN.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 1387000000.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -2500000000.00
AMGN.TO income_statement (quarterly, 2025-03-31) — Research And Development: 1486000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -27140000000.00
AMGN.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1687000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 537650624.00
AMGN.TO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 85000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 6207000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -38162000000.00
AMGN.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
AMGN.TO income_statement (quarterly, 2025-03-31) — Tax Provision: 243000000.00
AMGN.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.12
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 89367000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 60220000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Total Debt: 57381000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 6207000000.00
AMGN.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 6971000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 83160000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 62438000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 60152000000.00
AMGN.TO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 1178000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 2419000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Work In Process: 3961000000.00
AMGN.TO balance_sheet (quarterly, 2025-03-31) — Working Capital: 3921000000.00
AMGN.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 3512000000.00
AMGN.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 9179000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 3010000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 8701000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -10800000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 0.00
AMGN.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 9774618731.00
AMGN.TO income_statement (quarterly, 2025-06-30) — Basic EPS: 0.15
AMGN.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 8810000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -369000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 33680000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 8028000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 8028000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -1280000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -2673000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -389000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 2280000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 589000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Change In Income Tax Payable: -2325000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Change In Inventory: 239000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -206000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 8000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Change In Payable: -1736000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -673000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Change In Receivables: -515000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Change In Tax Payable: -2325000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -759000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -515000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: -782000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 33680000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -1280000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 7428000000.00
AMGN.TO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 3011000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 15022000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Current Assets: 26734000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Current Debt: 2444000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 2444000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 20476000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -422000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Deferred Tax: -422000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Depreciation: 1341000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 1341000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 1341000000.00
AMGN.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 9829124040.00
AMGN.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.15
AMGN.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 1432000000.00
AMGN.TO income_statement (quarterly, 2025-06-30) — EBIT: 2262000000.00
AMGN.TO income_statement (quarterly, 2025-06-30) — EBITDA: 3603000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 8028000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -2673000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Finished Goods: 2040000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 1911000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 554000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -544000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Goodwill: 18674000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 43288000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 17655000000.00
AMGN.TO income_statement (quarterly, 2025-06-30) — Gross Profit: 6168000000.00
AMGN.TO income_statement (quarterly, 2025-06-30) — Interest Expense: 694000000.00
AMGN.TO income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 694000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Inventory: 6583000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 63632000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -389000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 53760000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 53760000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -1000000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Net Debt: 48176000000.00
AMGN.TO income_statement (quarterly, 2025-06-30) — Net Income: 1432000000.00
AMGN.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 1432000000.00
AMGN.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 1432000000.00
AMGN.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 1432000000.00
AMGN.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 1432000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 1432000000.00
AMGN.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 1432000000.00
AMGN.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: -694000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -1000000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -1000000000.00
AMGN.TO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -694000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -393000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -20000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 6855000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -369000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -35860000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 1386000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 1386000000.00
AMGN.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 3603000000.00
AMGN.TO income_statement (quarterly, 2025-06-30) — Normalized Income: 1432000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 2280000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 554000000.00
AMGN.TO income_statement (quarterly, 2025-06-30) — Operating Income: 2656000000.00
AMGN.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 8771000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 538300000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 3422000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -544000000.00
AMGN.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: -394000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 24614000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -23000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 11020000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 2336000000.00
AMGN.TO income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -394000000.00
AMGN.TO income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 77000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Payables: 3010000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 18032000000.00
AMGN.TO income_statement (quarterly, 2025-06-30) — Pretax Income: 1568000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -369000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Raw Materials: 885000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 8701000000.00
AMGN.TO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 3011000000.00
AMGN.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 1341000000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -1000000000.00
AMGN.TO income_statement (quarterly, 2025-06-30) — Research And Development: 1744000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -25708000000.00
AMGN.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1691000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 538300000.00
AMGN.TO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 157000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 7428000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -35860000000.00
AMGN.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
AMGN.TO income_statement (quarterly, 2025-06-30) — Tax Provision: 136000000.00
AMGN.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.09
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 87897000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 61188000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Total Debt: 56204000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 7428000000.00
AMGN.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 6523000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 80469000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 61163000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 59993000000.00
AMGN.TO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 2656000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Tradeand Other Payables Non Current: 2511000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Work In Process: 3658000000.00
AMGN.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: 6258000000.00
AMGN.TO income_statement (quarterly, 2025-09-30) — +Operating Expense: 3949000000.00
AMGN.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 9557000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 2838000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 8490000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -11000000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 400000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 8028000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -436000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 33841000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 9445000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 9445000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -1282000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -2853000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -414000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 4684000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -174000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Change In Income Tax Payable: 684000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Change In Inventory: 240000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -283000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -10000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Change In Payable: 510000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -553000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Change In Receivables: 222000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Change In Tax Payable: 684000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 1663000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 222000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: 1417000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 33841000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -1282000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 9619000000.00
AMGN.TO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 3082000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 16800000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Current Assets: 27885000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Current Debt: 2153000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 2153000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 21791000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -30000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Deferred Tax: -30000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Depreciation: 1307000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 1307000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 1307000000.00
AMGN.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 3216000000.00
AMGN.TO income_statement (quarterly, 2025-09-30) — EBIT: 4606000000.00
AMGN.TO income_statement (quarterly, 2025-09-30) — EBITDA: 5913000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 9445000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -2853000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Finished Goods: 1836000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 4248000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -422000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Goodwill: 18676000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 41815000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 18220000000.00
AMGN.TO income_statement (quarterly, 2025-09-30) — Gross Profit: 6475000000.00
AMGN.TO income_statement (quarterly, 2025-09-30) — Interest Expense: 685000000.00
AMGN.TO income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 685000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Inventory: 6346000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 64206000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -414000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 52434000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 52434000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -1500000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Net Debt: 45142000000.00
AMGN.TO income_statement (quarterly, 2025-09-30) — Net Income: 3216000000.00
AMGN.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 3216000000.00
AMGN.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 3216000000.00
AMGN.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 3216000000.00
AMGN.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 3216000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 3216000000.00
AMGN.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 3216000000.00
AMGN.TO income_statement (quarterly, 2025-09-30) — Net Interest Income: -685000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -1500000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -1500000000.00
AMGN.TO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -685000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -71000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 22000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Net PPE: 7220000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -436000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -32196000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 1458000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 1458000000.00
AMGN.TO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 5913000000.00
AMGN.TO income_statement (quarterly, 2025-09-30) — Normalized Income: 3216000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 4684000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -1971000000.00
AMGN.TO income_statement (quarterly, 2025-09-30) — Operating Income: 2526000000.00
AMGN.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 9137000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 538500000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 3604000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -422000000.00
AMGN.TO income_statement (quarterly, 2025-09-30) — Other Income Expense: 2080000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 23139000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -28000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 13221000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 2223000000.00
AMGN.TO income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 2080000000.00
AMGN.TO income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 329000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Payables: 2838000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 19638000000.00
AMGN.TO income_statement (quarterly, 2025-09-30) — Pretax Income: 3921000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -436000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Raw Materials: 955000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Receivables: 8490000000.00
AMGN.TO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 3082000000.00
AMGN.TO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 1307000000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -1500000000.00
AMGN.TO income_statement (quarterly, 2025-09-30) — Research And Development: 1900000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -23800000000.00
AMGN.TO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 1720000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 538500000.00
AMGN.TO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 127000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 9619000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -32196000000.00
AMGN.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
AMGN.TO income_statement (quarterly, 2025-09-30) — Tax Provision: 705000000.00
AMGN.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.18
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 90141000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 62053000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Total Debt: 54587000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 9619000000.00
AMGN.TO income_statement (quarterly, 2025-09-30) — Total Expenses: 7031000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 80522000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 62256000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 58731000000.00
AMGN.TO income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 2526000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Tradeand Other Payables Non Current: 2616000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Work In Process: 3555000000.00
AMGN.TO balance_sheet (quarterly, 2025-09-30) — Working Capital: 6094000000.00
AMGN.TO income_statement (annual, 2025-12-31) — +Operating Expense: 15634000000.00
AMGN.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 4170000000.00
AMGN.TO income_statement (annual, 2025-12-31) — +Total Revenue: 36751000000.00
AMGN.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 9866000000.00
AMGN.TO balance_sheet (annual, 2025-12-31) — Accounts Payable: 2367000000.00
AMGN.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 2367000000.00
AMGN.TO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 9570000000.00
AMGN.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 9570000000.00
AMGN.TO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -11120000000.00
AMGN.TO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -11120000000.00
AMGN.TO cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 1200000000.00
AMGN.TO cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
AMGN.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 9774618731.00
AMGN.TO income_statement (quarterly, 2025-12-31) — Basic Average Shares: 9792787167.00
AMGN.TO income_statement (annual, 2025-12-31) — Basic EPS: 0.79
AMGN.TO income_statement (quarterly, 2025-12-31) — Basic EPS: 0.14
AMGN.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 11973000000.00
AMGN.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 9445000000.00
AMGN.TO balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 4932000000.00
AMGN.TO balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 4932000000.00
AMGN.TO cash_flow (annual, 2025-12-31) — Capital Expenditure: -1858000000.00
AMGN.TO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -642000000.00
AMGN.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 34023000000.00
AMGN.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 34023000000.00
AMGN.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 9129000000.00
AMGN.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 9129000000.00
AMGN.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 9129000000.00
AMGN.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 9129000000.00
AMGN.TO cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -5124000000.00
AMGN.TO cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -1283000000.00
AMGN.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -10859000000.00
AMGN.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -1226000000.00
AMGN.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1943000000.00
AMGN.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -693000000.00
AMGN.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 9958000000.00
AMGN.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 1603000000.00
AMGN.TO cash_flow (annual, 2025-12-31) — Change In Account Payable: 428000000.00
AMGN.TO cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -484000000.00
AMGN.TO cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 2065000000.00
AMGN.TO cash_flow (annual, 2025-12-31) — Change In Income Tax Payable: -1757000000.00
AMGN.TO cash_flow (quarterly, 2025-12-31) — Change In Income Tax Payable: -290000000.00
AMGN.TO cash_flow (annual, 2025-12-31) — Change In Inventory: 886000000.00
AMGN.TO cash_flow (quarterly, 2025-12-31) — Change In Inventory: 119000000.00
AMGN.TO cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -1267000000.00
AMGN.TO cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -577000000.00
AMGN.TO cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -156000000.00
AMGN.TO cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -76000000.00
AMGN.TO cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 499000000.00
AMGN.TO cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -1548000000.00
AMGN.TO cash_flow (annual, 2025-12-31) — Change In Payable: -1329000000.00
AMGN.TO cash_flow (quarterly, 2025-12-31) — Change In Payable: -774000000.00
AMGN.TO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 736000000.00
AMGN.TO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 1291000000.00
AMGN.TO cash_flow (annual, 2025-12-31) — Change In Receivables: -2676000000.00
AMGN.TO cash_flow (quarterly, 2025-12-31) — Change In Receivables: -1075000000.00
AMGN.TO cash_flow (annual, 2025-12-31) — Change In Tax Payable: -1757000000.00
AMGN.TO cash_flow (quarterly, 2025-12-31) — Change In Tax Payable: -290000000.00
AMGN.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: -1978000000.00
AMGN.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -1866000000.00
AMGN.TO cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -2676000000.00
AMGN.TO cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -1075000000.00
AMGN.TO cash_flow (annual, 2025-12-31) — Changes In Cash: -2844000000.00
AMGN.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: -316000000.00
AMGN.TO balance_sheet (annual, 2025-12-31) — Common Stock: 34023000000.00
AMGN.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 34023000000.00
AMGN.TO cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -5124000000.00
AMGN.TO cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -1283000000.00
AMGN.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 8658000000.00
AMGN.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 8658000000.00
AMGN.TO cash_flow (annual, 2025-12-31) — Common Stock Payments: 0.00
AMGN.TO balance_sheet (annual, 2025-12-31) — Construction In Progress: 3390000000.00
AMGN.TO balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 3390000000.00
AMGN.TO income_statement (annual, 2025-12-31) — Cost Of Revenue: 12037000000.00
AMGN.TO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 2976000000.00
AMGN.TO balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 15349000000.00
AMGN.TO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 15349000000.00
AMGN.TO balance_sheet (annual, 2025-12-31) — Current Assets: 29057000000.00
AMGN.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 29057000000.00
AMGN.TO balance_sheet (annual, 2025-12-31) — Current Debt: 4599000000.00
AMGN.TO balance_sheet (quarterly, 2025-12-31) — Current Debt: 4599000000.00
AMGN.TO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 4599000000.00
AMGN.TO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 4599000000.00
AMGN.TO balance_sheet (annual, 2025-12-31) — Current Liabilities: 25489000000.00
AMGN.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 25489000000.00
AMGN.TO cash_flow (annual, 2025-12-31) — Deferred Income Tax: -721000000.00
AMGN.TO cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -19000000.00
AMGN.TO cash_flow (annual, 2025-12-31) — Deferred Tax: -721000000.00
AMGN.TO cash_flow (quarterly, 2025-12-31) — Deferred Tax: -19000000.00
AMGN.TO cash_flow (annual, 2025-12-31) — Depreciation: 5167000000.00
AMGN.TO cash_flow (quarterly, 2025-12-31) — Depreciation: 1132000000.00
AMGN.TO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 5167000000.00
AMGN.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 1132000000.00
AMGN.TO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 5167000000.00
AMGN.TO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 1132000000.00
AMGN.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 9847292476.00
AMGN.TO income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 9865460912.00
AMGN.TO income_statement (annual, 2025-12-31) — Diluted EPS: 0.78
AMGN.TO income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.13
AMGN.TO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 7711000000.00
AMGN.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 1333000000.00
AMGN.TO balance_sheet (annual, 2025-12-31) — Dividends Payable: 1358000000.00
AMGN.TO balance_sheet (quarterly, 2025-12-31) — Dividends Payable: 1358000000.00
AMGN.TO income_statement (annual, 2025-12-31) — EBIT: 11731000000.00
AMGN.TO income_statement (quarterly, 2025-12-31) — EBIT: 2167000000.00
AMGN.TO income_statement (annual, 2025-12-31) — EBITDA: 16898000000.00
AMGN.TO income_statement (quarterly, 2025-12-31) — EBITDA: 3299000000.00
AMGN.TO cash_flow (annual, 2025-12-31) — End Cash Position: 9129000000.00
AMGN.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 9129000000.00
AMGN.TO cash_flow (annual, 2025-12-31) — Financing Cash Flow: -10859000000.00
AMGN.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -1226000000.00
AMGN.TO balance_sheet (annual, 2025-12-31) — Finished Goods: 1885000000.00
AMGN.TO balance_sheet (quarterly, 2025-12-31) — Finished Goods: 1885000000.00
AMGN.TO balance_sheet (annual, 2025-12-31) — Foreign Currency Translation Adjustments: -202000000.00
AMGN.TO balance_sheet (quarterly, 2025-12-31) — Foreign Currency Translation Adjustments: -202000000.00
AMGN.TO cash_flow (annual, 2025-12-31) — Free Cash Flow: 8100000000.00
AMGN.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 961000000.00
AMGN.TO cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -2064000000.00
AMGN.TO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -258000000.00